Review Article
A Current Review of Targeted Therapeutics for Ovarian Cancer
Table 4
PARP inhibitors and ovarian cancer.
| | clinical trial.gov ID | Therapeutic regimen | Study PI |
| | NCT00753545 | AZD2281 in platinum sensitive EOC | J. Lederman | | NCT00679783 | AZD2281 in known BRCA or recurrent EOC | K. Gelman | | NCT00749502 | MK4827 in BRCA mutant ovarian cancer | | NCT00664781 | AG014699 in BRCA mutant ovarian cancer | R. Plummer | | NCT00647062 | AZD2281 and carboplatin in BRCA mutant EOC | E. Kohn |
|
|
